Literature DB >> 20582964

Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.

Mette Møller Handrup1, Jens Kjølseth Møller, Morten Frydenberg, Henrik Schrøder.   

Abstract

BACKGROUND: Tunneled central venous catheters (CVCs) are inevitable in children with acute lymphoid leukemia (ALL). The aim of this study was to evaluate the risk of CVC-related complications in children with ALL in relation to timing of catheter placement and type of catheter. PROCEDURE: All children hospitalized from January 2000 to March 2008 with newly diagnosed ALL and with double-lumen total implantable devices (TIDs) or tunneled external catheters (TEs) were included retrospectively. We only used data related to the patient's first catheter.
RESULTS: We included 98 children; 35 received a TID and the remaining 63 received a TE. A total number of 29,566 catheter days and 93 catheter-associated blood stream infections (CABSI) was identified. We found a CABSI rate of 3.1/1,000 catheter days (5.4/1,000 catheter days for TEs and 1.4/1,000 catheter days for TIDs, incidence rate ratio (IRR) 3.82 (95% CI 2.37-6.35) P = 0.0001). No difference was found in CABSI between neither early versus later placed TIDs (IRR = 0.99 (95% CI 0.41-2.45) P = 0.98) nor early versus later placed TEs (IRR = 0.81 (95% CI 0.40-1.86) P = 0.54). We found no difference between early and later placed catheters regarding non-elective removal (RR = 0.86 (95% CI 0.72-1.03) P = 0.09). TEs had a higher risk of non-elective removal compared with TIDs (RR = 3.95 (95% CI 1.88-8.29) P < 0.001).
CONCLUSIONS: The study did not find that children with ALL and with early placed CVCs experienced significantly more complications compared with children with late placed catheters. This study found that children with ALL and TEs experienced more complications than children with TIDs. (c) 2010 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 20582964     DOI: 10.1002/pbc.22530

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  7 in total

1.  Safety of central venous catheter placement at diagnosis of acute lymphoblastic leukemia in children.

Authors:  G Gonzalez; A M Davidoff; S C Howard; C-H Pui; B N Rao; J L Shenep; A Wozniak; S J Shochat
Journal:  Pediatr Blood Cancer       Date:  2011-12-11       Impact factor: 3.167

2.  Implantable versus cuffed external central venous catheters for the management of children and adolescents with acute lymphoblastic leukaemia.

Authors:  Alan D White; Diaa Othman; Michael J Dawrant; Soroush Sohrabi; Alastair L Young; Roly Squire
Journal:  Pediatr Surg Int       Date:  2012-11-23       Impact factor: 1.827

3.  The risk of bloodstream infection associated with totally implantable venous access ports in cancer patient: a systematic review and meta-analysis.

Authors:  Meng Jiang; Chang-Li Li; Chun-Qiu Pan; Li Yu
Journal:  Support Care Cancer       Date:  2019-05-02       Impact factor: 3.603

Review 4.  Surveillance of bloodstream infections in pediatric cancer centers - what have we learned and how do we move on?

Authors:  Arne Simon; Rhoikos Furtwängler; Norbert Graf; Hans Jürgen Laws; Sebastian Voigt; Brar Piening; Christine Geffers; Philipp Agyeman; Roland A Ammann
Journal:  GMS Hyg Infect Control       Date:  2016-05-12

5.  Impact of Perioperative Absolute Neutrophil Count on Central Line-Associated Bloodstream Infection in Children With Acute Lymphoblastic and Myeloid Leukemia.

Authors:  Illya Martynov; Joachim Schoenberger
Journal:  Front Oncol       Date:  2021-11-23       Impact factor: 6.244

6.  Impact of a modified Broviac maintenance care bundle on bloodstream infections in paediatric cancer patients.

Authors:  Rhoikos Furtwängler; Carolin Laux; Norbert Graf; Arne Simon
Journal:  GMS Hyg Infect Control       Date:  2015-11-16

7.  Reduced central line infection rates in children with leukemia following caregiver training: A quality improvement study.

Authors:  Andrea Lo Vecchio; Joshua K Schaffzin; Eliana Ruberto; Maria Angela Caiazzo; Loredana Saggiomo; Daniela Mambretti; Danila Russo; Sara Crispo; Grazia Isabella Continisio; Rossano Dello Iacovo; Vincenzo Poggi; Alfredo Guarino
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.